One more reason to be amazed: the immune system not only defends against outside threats but also fights internal ones. In this edition’s main feature, senior writer Meghan Rosen shares a groundbreaking development in using the immune system to combat cancer. The FDA recently approved Amtagvi, the first T cell therapy for solid tumors. This treatment involves extracting tumor-infiltrating lymphocytes (TILs) from a patient’s tumor, multiplying them in the lab, and then injecting them back into the patient to enhance the body’s ability to fight cancer.
2024-08-24 06:00:00
Read more at www.sciencenews.org